Insider at

04

Insider transactions

05
0 buys (P) 2 sells (S) Net: $-4,685,094 + 98 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

98 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 10, 2026 MRNA S 10b5-1 19,836 $134.49 $2,667,744 74,375 Direct -21.05% Disposed 40.9% (price as of 2026-10-05)
Sept. 10, 2026 MRNA S 10b5-1 15,000 $134.49 $2,017,350 59,375 Direct -20.17% Disposed 40.9% (price as of 2026-10-05)

Showing latest 100 of 187 transactions

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 10, 2026 MRNA Stock Option (Right to Buy) Common Stock (19,836) $30.96 March 1, 2035 19,836 Disposed
Sept. 4, 2026 MRNA Restricted Stock Units Common Stock (11,797) · · 11,797 Disposed
Sept. 1, 2026 MRNA Restricted Stock Units Common Stock (2,475) · · 2,475 Disposed
Aug. 28, 2026 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Aug. 27, 2026 MRNA Restricted Stock Units Common Stock (774) · · 774 Disposed
July 2, 2026 MRNA Restricted Stock Units Common Stock (1,452) · · 1,452 Disposed
June 5, 2026 MRNA Restricted Stock Units Common Stock (11,798) · · 11,798 Disposed
June 1, 2026 MRNA Restricted Stock Units Common Stock (2,475) · · 2,475 Disposed
May 28, 2026 MRNA Restricted Stock Units Common Stock (328) · · 328 Disposed
May 27, 2026 MRNA Restricted Stock Units Common Stock (773) · · 773 Disposed
April 2, 2026 MRNA Restricted Stock Units Common Stock (1,453) · · 1,453 Disposed
March 5, 2026 MRNA Restricted Stock Units Common Stock (11,797) · · 11,797 Disposed
March 1, 2026 MRNA Stock Option (Right to Buy) Common Stock (37,639) $53.57 March 1, 2036 37,639 Acquired
March 1, 2026 MRNA Restricted Stock Units Common Stock (49,569) · · 49,569 Acquired
Feb. 27, 2026 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Feb. 27, 2026 MRNA Restricted Stock Units Common Stock (774) · · 774 Disposed
Feb. 27, 2026 MRNA Restricted Stock Units Common Stock (9,901) · · 9,901 Disposed
Jan. 5, 2026 MRNA Restricted Stock Units Common Stock (1,452) · · 1,452 Disposed
Dec. 5, 2025 MRNA Restricted Stock Units Common Stock (47,190) · · 47,190 Disposed
Nov. 28, 2025 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Nov. 26, 2025 MRNA Restricted Stock Units Common Stock (773) · · 773 Disposed
Oct. 3, 2025 MRNA Restricted Stock Units Common Stock (1,453) · · 1,453 Disposed
Aug. 28, 2025 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Aug. 27, 2025 MRNA Restricted Stock Units Common Stock (774) · · 774 Disposed
July 3, 2025 MRNA Restricted Stock Units Common Stock (1,453) · · 1,453 Disposed
May 28, 2025 MRNA Restricted Stock Units Common Stock (328) · · 328 Disposed
May 27, 2025 MRNA Restricted Stock Units Common Stock (773) · · 773 Disposed
April 4, 2025 MRNA Restricted Stock Units Common Stock (1,452) · · 1,452 Disposed
March 1, 2025 MRNA Restricted Stock Units Common Stock (39,606) · · 39,606 Acquired
March 1, 2025 MRNA Stock Option (Right to Buy) Common Stock (63,478) $30.96 March 1, 2035 63,478 Acquired
Feb. 28, 2025 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Feb. 27, 2025 MRNA Restricted Stock Units Common Stock (1,326) · · 1,326 Disposed
Feb. 27, 2025 MRNA Restricted Stock Units Common Stock (3,094) · · 3,094 Disposed
Feb. 27, 2025 MRNA Performance Stock Units Common Stock (1,326) · · 1,326 Disposed
Jan. 3, 2025 MRNA Restricted Stock Units Common Stock (1,453) · · 1,453 Disposed
Dec. 5, 2024 MRNA Restricted Stock Units Common Stock (188,761) $0.00 · 188,761 Acquired
Nov. 27, 2024 MRNA Restricted Stock Units Common Stock (1,326) · · 1,326 Disposed
Nov. 27, 2024 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Nov. 27, 2024 MRNA Performance Stock Units Common Stock (1,326) · · 1,326 Disposed
Oct. 4, 2024 MRNA Restricted Stock Units Common Stock (1,453) · · 1,453 Disposed
Aug. 28, 2024 MRNA Restricted Stock Units Common Stock (329) · · 329 Disposed
Aug. 27, 2024 MRNA Restricted Stock Units Common Stock (1,326) · · 1,326 Disposed
Aug. 27, 2024 MRNA Performance Stock Units Common Stock (1,326) · · 1,326 Disposed
July 5, 2024 MRNA Restricted Stock Units Common Stock (1,452) · · 1,452 Disposed
May 31, 2024 MRNA Performance Stock Units Common Stock (1,326) · · 1,326 Disposed
May 31, 2024 MRNA Performance Stock Units Common Stock (5,304) · · 5,304 Acquired
May 28, 2024 MRNA Restricted Stock Units Common Stock (328) · · 328 Disposed
May 24, 2024 MRNA Restricted Stock Units Common Stock (1,326) · · 1,326 Disposed
April 5, 2024 MRNA Restricted Stock Units Common Stock (1,453) · · 1,453 Disposed
Feb. 28, 2024 MRNA Restricted Stock Units Common Stock (1,315) · · 1,315 Disposed
Feb. 27, 2024 MRNA Stock Option (Right to Buy) Common Stock (23,635) $96.20 Feb. 27, 2034 23,635 Acquired
Feb. 27, 2024 MRNA Restricted Stock Units Common Stock (12,377) $0.00 · 12,377 Acquired
Feb. 27, 2024 MRNA Stock Option (Right to Buy) Common Stock (60,216) $96.20 Feb. 27, 2034 60,216 Acquired
Feb. 27, 2024 MRNA Restricted Stock Units Common Stock (5,304) $0.00 · 5,304 Acquired
Jan. 5, 2024 MRNA Restricted Stock Units Common Stock (1,452) · · 1,452 Disposed
Oct. 5, 2023 MRNA Restricted Stock Units Common Stock (5,810) · · 5,810 Disposed
Feb. 28, 2023 MRNA Restricted Stock Units Common Stock (5,260) $0.00 · 5,260 Acquired
Feb. 28, 2023 MRNA Stock Option (Right to Buy) Common Stock (20,040) $138.81 Feb. 28, 2033 20,040 Acquired
Oct. 5, 2022 MRNA Restricted Stock Units Common Stock (23,242) $0.00 · 23,242 Acquired
Oct. 5, 2022 MRNA Stock Option (Right to Buy) Common Stock (43,876) $125.62 Oct. 5, 2032 43,876 Acquired
Feb. 4, 2022 RVTY NQ Stock Option (right to buy) Common Stock (9,771) $184.61 Feb. 4, 2029 9,771 Acquired
Feb. 5, 2021 RVTY NQ Stock Option (right to buy) Common Stock (11,125) $144.33 Feb. 5, 2028 11,125 Acquired
Jan. 30, 2020 RVTY NQ Stock Option (right to buy) Common Stock (15,817) $96.06 Jan. 30, 2027 15,817 Acquired
Feb. 5, 2019 RVTY NQ Stock Option (right to buy) Common Stock (13,598) $92.09 Feb. 5, 2026 13,598 Acquired
May 15, 2018 RVTY NQ Stock Option (right to buy) Common Stock (17,038) · May 15, 2025 17,038 Acquired
May 15, 2018 RVTY NQ Stock Option (right to buy) Common Stock (17,038) $73.83 May 15, 2025 17,038 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2018 $331,154 $400,000 · · $641,813 · $8,268 $4,266,616

MRNA

CFO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2023 $792,308 · · · $583,200 · $21,100 $4,317,185
2022 $227,885 $1,000,000 · · $259,644 · $4,327 $7,331,196

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.